Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.
World Neurosurg. 2024 Jul;187:e509-e516. doi: 10.1016/j.wneu.2024.04.118. Epub 2024 Apr 25.
In patients undergoing metastatic spine surgery, we sought to 1) report time to postoperative radiation therapy (RT), 2) describe the predictive factors of time to postoperative RT, and 3) determine if earlier postoperative RT is associated with improved local recurrence (LR) and overall survival (OS).
A single-center retrospective cohort study was undertaken of all patients undergoing spine surgery for extradural metastatic disease and receiving RT within 3 months postoperatively between January 2010 and January 2021. Time to postoperative RT was dichotomized at <1 month versus 1-3 months. The primary outcomes were LR, OS, and 1-year survival. Secondary outcomes were wound complication, Karnofsky Performance Status, and modified McCormick Scale (MMS) score. Regression analyses controlled for age, body mass index, tumor size, preoperative RT, preoperative/postoperative chemotherapy, and type of RT.
Of 76 patients undergoing spinal metastasis surgery and receiving postoperative RT within 3 months, 34 (44.7%) received RT within 1 month and 42 (55.2%) within 1-3 months. Patients with larger tumor size (β = -3.58; 95% confidence interval [CI], -6.59 to -0.57; P = 0.021) or new neurologic deficits (β = -16.21; 95% CI, -32.21 to -0.210; P = 0.047) had a shorter time to RT. No significant association was found between time to RT and LR or OS on multivariable logistic/Cox regression. However, patients who received RT between 1 and 3 months had a lower odds of 1-year survival compared with those receiving RT within 1 month (odds ratio, 0.18; 95% CI, 0.04-0.74; P = 0.022). Receiving RT within 1 month versus 1-3 months was not associated with wound complications (7.1% vs. 2.9%; P = 0.556) (odds ratio, 4.40; 95% CI, 0.40-118.0; P = 0.266) or Karnofsky Performance Status/modified McCormick Scale score.
Spine surgeons, oncologists, and radiation oncologists should make every effort to start RT within 1 month to improve 1-year survival after metastatic spine tumor surgery.
在接受转移性脊柱手术的患者中,我们旨在:1)报告术后放疗(RT)的时间;2)描述术后 RT 时间的预测因素;3)确定术后早期 RT 是否与局部复发(LR)和总生存(OS)改善相关。
回顾性分析了 2010 年 1 月至 2021 年 1 月期间在单中心行脊柱手术治疗硬膜外转移性疾病并在术后 3 个月内行 RT 的所有患者的资料。将术后 RT 时间分为<1 个月和 1-3 个月。主要结局是 LR、OS 和 1 年生存率。次要结局是伤口并发症、卡氏功能状态评分(KPS)和改良 McCormick 分级(MMS)评分。回归分析控制了年龄、体重指数、肿瘤大小、术前 RT、术前/术后化疗以及 RT 类型。
在 76 例接受脊柱转移瘤手术并在术后 3 个月内行 RT 的患者中,34 例(44.7%)在 1 个月内接受 RT,42 例(55.2%)在 1-3 个月内接受 RT。肿瘤较大(β=-3.58;95%置信区间,-6.59 至-0.57;P=0.021)或出现新的神经功能缺损(β=-16.21;95%置信区间,-32.21 至-0.210;P=0.047)的患者 RT 时间更短。多变量逻辑/ Cox 回归分析未发现 RT 时间与 LR 或 OS 之间存在显著相关性。然而,与 1 个月内接受 RT 的患者相比,1-3 个月内接受 RT 的患者 1 年生存率较低(比值比,0.18;95%置信区间,0.04-0.74;P=0.022)。与 1-3 个月内接受 RT 相比,1 个月内接受 RT 与伤口并发症(7.1%比 2.9%;P=0.556)(比值比,4.40;95%置信区间,0.40-118.0;P=0.266)或 KPS/MMS 评分无关。
脊柱外科医生、肿瘤学家和放射肿瘤学家应尽最大努力在 1 个月内开始 RT,以改善转移性脊柱肿瘤手术后的 1 年生存率。